Advanced Search

Share

English Português

Home Most often read

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more

Impact factor 2022

2.1

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2018

1.4

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2017

0.335

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2017

0.455

View more metrics

Open Access Option

Journal Information

Most often read

Vol. 47. Issue. 2

858

Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)

Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia

Hematol Transfus Cell Ther. 2025;47:103822

858

Full text access

Share

644

Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review

Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira

Hematol Transfus Cell Ther. 2025;47:103736

644

Full text access

Share

635

Optimization of hydroxyurea in sickle cell disease in Brazil

Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado

Hematol Transfus Cell Ther. 2025;47:103826

635

Full text access

Share

492

Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis

Luana Joana Barreto Cabral, Daniela Pereira Lopes, Eduardo dos Santos Martins Filho, Rubenilson Caldas Valois, Paula Christine Amarantes Justino Oliveira, Patrícia Jeanne de Souza Mendonça-Mattos

Hematol Transfus Cell Ther. 2025;47:103821

492

Full text access

Share

477

Spinal cord leptomeningeal myelomatosis

Gustavo Kazuo Silva Yamada, Guilherme Duffles, Carmino Antonio de Souza, Fabiano Reis

Hematol Transfus Cell Ther. 2025;47:103745

477

Full text access

Share

473

Lack of association between the TMPRSS6 gene polymorphism (rs855791) and anemia: a comprehensive meta-analysis

Jethendra Kumar Muruganantham, Ramakrishnan Veerabathiran

Hematol Transfus Cell Ther. 2025;47:103737

473

Full text access

Share

446

A common ground: an in silico assessment of the sources of intrinsic ex vivo resistance to venetoclax in acute myeloid leukemia

Brunno Gilberto Santos de Macedo, Manuela Albuquerque de Melo, Diego Antonio Pereira-Martins, João Agostinho Machado-Neto, Fabiola Traina

Hematol Transfus Cell Ther. 2025;47:103758

446

Full text access

Share

420

Impact of the creation of a multidisciplinary amyloidosis study group in a public hospital of a developing Latin American country

Camila Peña, José Manuel Matamala, Cristián Vargas, Jaime Álvarez, Ricardo Valjalo, Fernando J. Verdugo

Hematol Transfus Cell Ther. 2025;47:103820

420

Full text access

Share

418

Assessing the genetic profile of cytochrome P450 and glutathione S-transferases of patients diagnosed with acute myeloid leukemia

Gilmar de Andrade França, Luciana Nardinelli, Ricardo Rodrigues Giorgi, Thiago Pagliarini, Otávio César Carvalho Guimarães Baiocchi, Elvira Deolinda Rodrigues Pereira Velloso, Wellington Fernandes da Silva Jr, Eduardo Magalhães Rego, Israel Bendit

Hematol Transfus Cell Ther. 2025;47:103759

418

Full text access

Share

414

Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia

Anali Del Milagro Bernabe Garnique, Jorge Antonio Elias Godoy Carlos, Natalia Sudan Parducci, Mauricio Temotheo Tavares, Karoline de Barros Waitman, Keli Lima, Leticia Veras Costa-Lotufo, Roberto Parise-Filho, João Agostinho Machado-Neto

Hematol Transfus Cell Ther. 2025;47:103757

414

Full text access

Share

411

Outcomes and vaccination patterns against COVID-19 in a cohort of sickle cell disease patients in the state of Rio de Janeiro

Claudia de Alvarenga Maximo, Jorge Francisco da Cunha Pinto, Fabiana Canedo Pinto, Patrícia Brasil

Hematol Transfus Cell Ther. 2025;47:103824

411

Full text access

Share

379

Clinical and laboratorial characterization of a cohort of patients with hereditary platelet disorders in Brazil

Letícia Dalla Vecchia Grassi, Erica Okazaki, Cynthia Rothschild, Paula Villaça, Fernanda Andrade Orsi, Bianca Stefanello

Hematol Transfus Cell Ther. 2025;47:103837

379

Full text access

Share

373

Ocular graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in a pediatric population

Cinthia Kim, Patricia Cabral Zacharias Serapicos, Cintia Monteiro Lustosa, Adriane da Silva Santos Ibanez, Victor Gottardello Zecchin, Lauro Augusto de Oliveira

Hematol Transfus Cell Ther. 2025;47:103823

373

Full text access

Share

354

Effect of fibrin on the expression of adhesion molecules (ICAM-1, ITGAV, and ITGB3) in unrestricted somatic stem cells

Sanaz Khaseb, Mahdi Kohansal Vajari, Mina Soufi Zomorrod, Maryam Rezai Rad, Monireh Ajami, Mansoureh Ajami, Saba Sadeghpour, Amir Atashi

Hematol Transfus Cell Ther. 2025;47:103827

354

Full text access

Share

342

Problems with single platforms for CD34+ quantification: How aware are Brazilian hematologists and transplant specialists about them?

Daniel Mazza Matos

Hematol Transfus Cell Ther. 2025;47:103836

342

Full text access

Share

336

Evidence-based medicine during the COVID-19 pandemic: A hematologist's perspective

Yung Gonzaga

Hematol Transfus Cell Ther. 2025;47:103825

336

Full text access

Share

322

Iron overload is not the same everywhere: Particularities of iron-metabolism gene mutations in Brazil and a proposal for the investigation and management of iron overload in this population

Paula de Melo Campos, Ana Carolina Toreli, Dulcinéia Martins de Albuquerque, Fernando Ferreira Costa

Hematol Transfus Cell Ther. 2025;47:103846

322

Full text access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics